Remdesivir triphosphate blocks DNA synthesis and increases exonucleolysis by the replicative mitochondrial DNA polymerase, Pol γ
Document Type
Article
Publication Date
11-1-2021
Subject Area
Adenosine Monophosphate (analogs & derivatives, pharmacology); Alanine (analogs & derivatives, pharmacology); COVID-19 (metabolism); Cells, Cultured; DNA Polymerase gamma (metabolism); DNA Replication (drug effects); DNA, Mitochondrial (biosynthesis); Fibroblasts (metabolism); Humans; SARS-CoV-2; COVID-19 Drug Treatment
Abstract
The COVID-19 pandemic prompted the FDA to authorize a new nucleoside analogue, remdesivir, for emergency use in affected individuals. We examined the effects of its active metabolite, remdesivir triphosphate (RTP), on the activity of the replicative mitochondrial DNA polymerase, Pol γ. We found that while RTP is not incorporated by Pol γ into a nascent DNA strand, it remains associated with the enzyme impeding its synthetic activity and stimulating exonucleolysis. In spite of that, we found no evidence for deleterious effects of remdesivir treatment on the integrity of the mitochondrial genome in human cells in culture.
Publication Title
Mitochondrion
Volume
61
First Page
147
Last Page
158
Digital Object Identifier (DOI)
10.1016/j.mito.2021.09.010
PubMed ID
34619353
E-ISSN
1872-8278
Language
eng
Citation Information
Ciesielska, Elena J.; Kim, Shalom; Bisimwa, Hyacintha-Ghislaine M.; Grier, Cody; Rahman, Md Mostafijur; Young, Carolyn K.; Young, Matthew J.; Oliveira, Marcos T.; and Ciesielski, Grzegorz L., "Remdesivir triphosphate blocks DNA synthesis and increases exonucleolysis by the replicative mitochondrial DNA polymerase, Pol γ" (2021). UNF Faculty Research and Scholarship. 3278.
https://digitalcommons.unf.edu/unf_faculty_publications/3278